Helmut Butzkueven

35PUBLICATIONS
197CO-AUTHORS
Molecular targetsGene and molecular therapyMedical infection agents (incl. prions)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 01, 2026
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

|Apr 07, 2026
Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors.

Wei Zhen Yeh, Fiona Chan, Anna Francis

|Apr 01, 2026
Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.

Michael T G Hayes, Heidi N Beadnall, Daniel Merlo

|Apr 01, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Andrea Surcinelli, Tomas Kalincik, Izanne Roos

|Mar 05, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt

Pageof 6

Frequent Collaborators

23 joint publications

Anneke Van Der Walt

13 joint publications

Tomas Kalincik

10 joint publications

Vilija Jokubaitis

9 joint publications

Francesco Patti